Merck opens latest 2,700 square metre commercial facility in France
![](/46/pdcnewsitem/11/89/50/CPHI%20online%20images%20(21).png)
Merck opens their latest commercial manufacturing facility in Martillac, France, boasting rapid development and commercialisation of drug products with streamlined processes and state-of-the-art technology.
German science and technology company Merck's latest 2,700 square metre commercial facility has officially opened in Martillac, France as part of its new Millipore CTDMO Services for monoclonal antibodies and other recombinant proteins.
With two 2000-litre bioreactors in one manufacturing facility, the new site will deliver high levels of efficiency with the ability to rapidly pivot from 200 to 2000 litres of drug substance. Merck clients will be able to accelerate the commercialisation process of their products with the elimination of tech transfer and scale-up requirements between the clinical and commercial stages. Characterisation and safety testing integrated into differentiated CTDMO services will further streamline the development and commercialisation of drug products for Merck customers. All services will fall under the Millipore CTDMO Services offerings ranging from preclinical to commercial phases for therapeutic modalities including mAbs, highly potent active pharmaceutical ingredients, antibody–drug conjugates, viral vector therapies, mRNA, and lipid nanoparticle formulation.
Head of Life Science Services, Life Science business sector at Merck Dirk Lange commented: “Our clients are pioneering modern medicine and managing multiple partners, supply chain needs and complex priorities, and are turning to Merck to help them navigate the complexity and provide flexibility and scale... With this facility and our global Millipore CTDMO Services network, we offer truly differentiated services, including templates for drug development, manufacturing, and commercialisation to accelerate molecules to market with one experienced partner.”
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles. -
News 2024 Pharma Industry Trends Outlook: Collaboration, Market Maturity, and Digital Futures
The annual CPHI Online 2024 Pharma Trends Outlook, in partnership with Arvato Systems, identifies 12 key industry trends shaping the life sciences industry in the coming year. -
News New Novo Nordisk AI hub for drug discovery to open in London, UK
Danish pharmaceutical giant Novo Nordisk will be opening an AI-based research facility in the heart of London to advance drug discovery operations. -
News BioNTech to begin mRNA vaccine manufacturing in Rwanda by 2025
German biotechnology company BioNTech has stated their intentions to begin production at their mRNA vaccine factory in Rwanda by 2025, which will mark the first foreign mRNA vaccine manufacturing site on the continent of Africa. -
News Women in Pharma: Looking back on 2023 and moving forward to 2024
In this monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance